ProfileGDS4718 / 1555469_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 56% 55% 58% 61% 61% 59% 53% 60% 63% 60% 60% 60% 61% 55% 57% 57% 58% 61% 65% 58% 61% 54% 56% 58% 56% 60% 58% 60% 61% 62% 57% 58% 55% 61% 60% 60% 53% 61% 57% 59% 64% 60% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0343159
GSM549102patient 115, normal, homogenized [OPG study]5.8750756
GSM549104patient 119, normal, homogenized [OPG study]5.8322355
GSM549108patient 138, normal, homogenized [OPG study]6.0227458
GSM549119patient 077, normal, homogenized [OPG study]6.1651461
GSM549133patient 032, cancer, homogenized [OPG study]6.1915561
GSM549139patient 042, cancer, homogenized [OPG study]6.0456459
GSM549099patient 107, normal, homogenized [OPG study]5.6763853
GSM549109patient 139, normal, homogenized [OPG study]6.1645860
GSM549110patient 046, normal, homogenized [OPG study]6.3087963
GSM549114patient 063, normal, homogenized [OPG study]6.0759160
GSM549122patient 082, normal, homogenized [OPG study]6.1681260
GSM549134patient 033, cancer, homogenized [OPG study]6.099160
GSM549136patient 036, cancer, homogenized [OPG study]6.1805561
GSM549140patient 044, cancer, homogenized [OPG study]5.7632355
GSM549111patient 047, normal, homogenized [OPG study]5.9039457
GSM549113patient 057, normal, homogenized [OPG study]5.9119957
GSM549132patient 031, cancer, homogenized [OPG study]6.0138258
GSM549137patient 038, cancer, homogenized [OPG study]6.1844561
GSM549142patient 047, cancer, homogenized [OPG study]6.5222865
GSM549100patient 110, normal, homogenized [OPG study]5.9841858
GSM549107patient 135, normal, homogenized [OPG study]6.1558661
GSM549115patient 068, normal, homogenized [OPG study]5.6770854
GSM549116patient 072, normal, homogenized [OPG study]5.8433456
GSM549120patient 078, normal, homogenized [OPG study]6.02358
GSM549131patient 030, cancer, homogenized [OPG study]5.8072956
GSM549118patient 074, normal, homogenized [OPG study]6.1334760
GSM549129patient 027, cancer, homogenized [OPG study]6.0191258
GSM549123patient 088, normal, homogenized [OPG study]6.1150660
GSM549124patient 006, cancer, homogenized [OPG study]6.1868861
GSM549126patient 015, cancer, homogenized [OPG study]6.2538262
GSM549128patient 025, cancer, homogenized [OPG study]5.93557
GSM549103patient 117, normal, homogenized [OPG study]6.0378258
GSM549117patient 073, normal, homogenized [OPG study]5.775955
GSM549138patient 041, cancer, homogenized [OPG study]6.1753361
GSM549141patient 045, cancer, homogenized [OPG study]6.0980460
GSM549130patient 028, cancer, homogenized [OPG study]6.1277760
GSM549101patient 111, normal, homogenized [OPG study]5.742753
GSM549105patient 128, normal, homogenized [OPG study]6.1730261
GSM549106patient 134, normal, homogenized [OPG study]5.921257
GSM549112patient 048, normal, homogenized [OPG study]6.0574159
GSM549125patient 011, cancer, homogenized [OPG study]6.366964
GSM549127patient 024, cancer, homogenized [OPG study]6.1775760
GSM549135patient 035, cancer, homogenized [OPG study]5.7829855